A total of 50 patients were
included in the mirror-design naturalistic study. The types of service
utilization, medication costs, and overall costs were measured in a
1-year period prior to and then after quetiapine initiation. Clinical
measures to document symptom improvement were done at medication
initiation and 6 months later.
- 72% reduction in inpatient utilization occurred after medication was initiated.
- 60% reduction in acute ER utilization
- 170% increase in outpatient services correlating with greater patient stabilization
- Overall mean costs savings of $12 per pt/month. (n=50)
- Significant improvement in symptoms of schizophrenia PANSS score decreased by 20%-60%
Service Utilization Changes
Intent to Treat: Cost Changes
Mean Cost Change Over 2 Years